Viruses use elaborate stratagems to enter cells. The HIV-1 envelope glycoprotein, which mediates both attachment and membrane fusion, has grudgingly begun to yield high-resolution structural information that suggests mechanistic similarities with the hemagglutinin protein of influenza virus.
The HIV and influenza fusion proteins, despite the lack of detectable sequence homology, share several general structural features [1, 9] . Both are homotrimers; the subunits are synthesized as single polypeptide chains that are subsequently cleaved, yielding, in the case of HIV-1, gp120 and gp41, and in the case of influenza, HA 1 and HA 2 . The smaller carboxy-terminal fragment -gp41 or HA 2 -remains anchored in the viral membrane and seems to play a direct role in membrane fusion. In particular, the hydrophobic stretch of residues at the amino-terminus of the newly-created gp41 or HA 2 chain appears to insert into the cell membrane prior to fusion, and is called the 'fusion peptide'. Between the fusion peptide sequence and the transmembrane domain lie regions composed of heptad repeats of hydrophobic residues that are predicted to form α-helical coiled coils [10] .
Figure 1
Comparative anatomy of trimeric viral fusion proteins. The individual subunits are colored red, green and blue. (a) HIV-1 gp41 [8] . The first twenty-nine gp41 residues, including the fusion peptide, are replaced by a modified GCN4 sequence that by itself forms a trimeric coiled coil [23] . The other gp41 structure [7] includes gp41 residues 35-70 and 117-150 and agrees closely with that shown here. (b) Moloney murine leukemia virus transmembrane subunit [6] . (c) Low pHinduced structure of influenza virus HA 2 subunit [4] . (d) Neutral pH structure of influenza virus HA 2 subunit [3] . The HA 1 subunits are omitted for clarity. (Reproduced with permission from [8] .)
Influenza virus hemagglutinin, solubilized by removal of its transmembrane anchor, was the first viral glycoprotein to have its atomic structure determined by X-ray crystallography [3] . In the structure, the three HA 2 chains (analogous to gp41) are seen to form a trimeric 'stem' built around three long central α-helices. The HA 1 chains (analogous to gp120) contribute somewhat to the stem, but the main central portion of each HA 1 chain forms a globular 'head' domain that sits atop the stem, distal to the viral membrane. Not surprisingly, each of the three globular head domains has a binding site for sialic acid, the cellular receptor [11] .
The fusion peptide sequences at the amino-termini of the HA 2 chains are tucked away into the interior of the stem domain (Figure 1d ), a puzzling location given the evidence that they interact with the cell membrane prior to fusion [12] . The resolution to this conundrum required a decade of work, during which it was realized that hemagglutinin undergoes a dramatic conformational change after a virus particle binds to a cell and is internalized by receptor-mediated endocytosis [1] . This conformational change, triggered by the low pH of the endosome, leads to the fusion of viral and endosomal membranes, releasing the viral nucleocapsid into the cytoplasm of the cell.
Purified hemagglutinin also changes conformation upon exposure to pH 5-6, presumably adopting the 'fusogenic' conformation. Although it has not proved possible to crystallize low-pH-treated intact hemagglutinin, the crystal structures of two relatively large proteolytic fragments have been determined. One fragment, comprising most of HA 1 (complexed with a neutralizing antibody), displays no significant change relative to the initial, neutral-pH structure [13] . This result implies that the globular fold of the head domains is not pH-sensitive, although there is evidence that the head domains move as units during the conformational change [2] .
The other proteolytic fragment of the low-pH-treated hemagglutinin for which structural information is available is a trimeric piece containing much of the HA 2 chain (Figure 1c ) [4] . To render this fragment water-soluble, both the carboxy-terminal transmembrane anchor and the amino-terminal hydrophobic fusion peptide sequence were proteolytically removed. Compared with the neutral pH structure, the low-pH-treated HA 2 chain is seen to have undergone a dramatic conformational change ( Figure  1c,d ). The core of the structure, composed of a thirtyresidue, triple-stranded coiled coil, remains unchanged. In the neutral pH structure, the region amino-terminal to this coiled coil forms an extended loop preceded by an α helix that packs against -and antiparallel to -the coiled coil. In the low-pH-structure, however, this hairpin-like arrangement has straightened out to form a single coiled coil, sixty-six residues long. Although amino-terminal residues including the fusion peptide were proteolytically removed, the extension of the coiled coil would relocate these residues about 100 Å to the 'top' of the molecule, in position to insert into the target cell membrane.
The straightening-out of one 'helix hairpin' is accompanied by the emergence of a different one. This second aspect of the low-pH-induced conformational change relocates and rearranges structures at the viral membrane end of the neutral pH hemagglutinin [4] , affecting the conformation of the carboxy-terminal part of the HA 2 chain between the invariant coiled coil segment and the transmembrane anchor. In the low-pH-induced conformation, the residues immediately following the trimeric coiled coil jack-knife up to pack against it, forming an antiparallel helix that appears quite securely positioned by an extensive hydrophobic interface. This helix is followed by a meandering set of structural elements that, at least as judged by crystallographic B factors, do not seem as firm, and the course of the polypeptide chain near the transmembrane anchor is not discernible. Nonetheless, it can be seen that the net effect of the low-pH-induced conformational change is to bring the last visible residue in the polypeptide chain (residue 162) rather close (~30 Å) to the first (residue 40) (Figure 1c ). This second aspect of the 'fusogenic' structure has, perhaps, been somewhat underemphasized; however, its forceful reappearance in the new gp41 structures seems to call for a revaluation of its significance (see below).
Unlike influenza virus, HIV-1 enters a cell at its surface, in a pH-independent manner. Like influenza virus, however, activation of the HIV-1 viral fusion protein requires conformational changes, in this case triggered by binding to the cellular receptor CD4 and subsequently to a coreceptor [14] [15] [16] . Several HIV-1 fusion cofactors have recently been found to be members of the chemokine receptor family. These conformational changes have not been characterized in detail as, until recently, the HIV-1 envelope protein had rebuffed all attempts at obtaining diffraction-quality crystals. Now, however, two groups have determined the crystal structures of slightly different core fragments of the HIV-1 gp41 ectodomain (the portion exterior to the viral membrane), apparently in the fusogenic conformation [7, 8] .
These new structures represent a relatively small (~10%) but important part of the gp120-gp41 complex -the stable core of the gp41 ectodomain. Kim and coworkers [17] had previously found that the bacterially-expressed gp41 ectodomain, though aggregated, could be digested with non-specific proteases to yield a defined, stable, soluble core domain. This domain is composed of two peptides separated by thirty-three residues in the gp41 sequence: one peptide (N-51; named for its length), was derived from an amino-terminal region adjacent to the fusion peptide, whereas the second peptide (C-43) was derived from sequences nearer the transmembrane domain.
Equilibrium ultracentrifugation revealed that this stable core domain has three N-51 peptides and three C-43 peptides; circular dichroism (CD) suggested that the domain is essentially 100% α-helical. Based on these and other results, Kim and coworkers [17] proposed a model for the core domain, in which the three N-51 peptides form a triple-stranded α-helical coiled coil in the center, while the three C-43 peptides form helices that pack in an antiparallel fashion into the grooves between adjacent N-51 helices. This model was bolstered by very similar results for the simian immunodeficiency virus (SIV) gp41 protein that led to an analogous model [18] .
In the models for both HIV-1 and SIV gp41 [17, 18] , the conserved, mostly hydrophobic residues at the a and d heptad positions of the N helices pack together at the core of a three-stranded coiled coil. The e and g heptad positions are also conserved and rather hydrophobic, creating non-polar grooves between adjacent N helices on the outer surface of the coiled coil. According to the model, the C helices pack against the outside of the coiled coil by projecting their hydrophobic a and d residues into this non-polar groove. The recent structures [7, 8] represent the gp41 core domain reconstituted from peptides corresponding to similar portions of the N and C helices. Although some interesting subtleties involving shifts in the heptad register of the outer helices were not anticipated [8] , the crystal structures show that the HIV-1 model [17] -and presumably also the SIV model [18] are essentially correct.
The structure of the HIV gp41 core domain (Figure 1a ) has striking similarities to the low-pH-induced HA 2 structure discussed above [7, 8] . In both cases, sequences adjacent to the amino-terminal fusion peptide form a triple-stranded coiled coil buttressed by antiparallel helices derived from more carboxy-terminal sequences. The crystal structure of a shorter fragment of the Moloney murine leukemia virus transmembrane protein (MMLV-TM) also revealed a central three-stranded coiled coil (Figure 1b) [6] . In this case, the structure of the region corresponding to the buttressing helix has not yet been determined. Nonetheless, longer fragments of MMLV-TM including this region have been characterized by CD, which revealed a helix content consistent with the presence of a buttressing helix [19] .
The HA 2 structure was the first to imply that the fusion peptide and transmembrane domain might be close together at the same end of the extended 'fusogenic' conformation triggered by low pH (see above), a possibility further supported by biochemical experiments using membrane-embedded HA 2 [20] . This feature has now reappeared in the structures of two different retroviral fusion proteins, gp41 and MMLV-TM. During and after fusion, therefore, it seems likely (and sensible) that the fusion protein segments embedded in the two fusing membranes come quite near to one another ( Figure 2 ) [8] .
To accomplish this, hemagglutinin -and perhaps the retroviral fusion proteins -undergoes at least two conceptually distinguishable conformational rearrangements [2] .
In the first rearrangement, the coiled coil extends, propelling the fusion peptide toward the cellular membrane and away from the transmembrane domain that anchors the protein in the viral membrane. In the second rearrangement, a further refolding of the ectodomain, this time involving a more carboxy-terminal region, brings the fusion peptide back into the vicinity of the transmembrane domain. These rearrangements seem likely to be Dispatch R567 Model for the membrane fusion mechanism of viral envelope proteins [8] . Conformational changes expose the fusion peptide, which becomes embedded in the cellular membrane. Further structural rearrangements in the protein accompany the close approach of the viral and cellular membranes, bringing the transmembrane anchor and fusion peptide into relative proximity, where they remain after fusion is completed. Cellular receptors are omitted for clarity.
sequential, as before the first rearrangement the 'docking site' for the carboxy-terminal region against the coiled coil is blocked by the fusion peptide and adjacent sequences. An intriguing possibility, consistent with the known structures, is that this second rearrangement could accompany close apposition of the two membranes [4, 8] .
Assuming that the features now visualized in three different fusion proteins represent the fusogenic conformation accurately, and that the two membranes are not grossly deformed during apposition, then there is seemingly no alternative to a model in which the fusion proteins, which are tall and skinny, lie down as they become sandwiched between the approaching bilayers ( Figure 2 ). This process would be facilitated by the flexibility that appears to characterize the region of the ectodomain closest to the viral membrane [4] , presumably allowing the entire trimer to bend readily with respect to the membrane. Such a model is the distant descendent of much earlier ones based on a simpler assumption: that the fusion peptide, although it becomes exposed by the activating conformational change, remains basically in the same place. Were this the case, the fusion peptide, as it is in native hemagglutinin, would be relatively near the transmembrane domain. Ironically, the emerging new model envisions a highly dynamic molecule in which the fusion peptide is ejected and moves over a great distance, after which the protein doubles up again to bring the fusion peptide back into the vicinity of the transmembrane domain.
Although this model has significant experimental support in the case of hemagglutinin, it is less clear that gp41 undergoes such extensive molecular gymnastics. In particular, it is not known whether the central coiled coil is extended by the conformational change or exists at full length throughout the lifetime of the molecule, protected from premature exposure by interactions with the gp120 subunit. Perhaps the intimacy of the HIV-1 envelope protein's sequential interactions with CD4 and a seventransmembrane-helix chemokine receptor [15, 16] obviates the need for the gp41 subunit to harpoon the cell membrane in such a dramatic way. But it remains possible that the gp41 coiled coil is formed or extended during the receptor/coreceptor-induced conformational change [7, 8] .
At present, though, the element of the hemagglutinin conformational change that seems most likely to be emulated by the retroviral proteins is the formation of an antiparallel structure that could serve to bring the fusion peptide and transmembrane domain into proximity (Figures 1,2) . Strong, albeit indirect, evidence suggests that this antiparallel structure does not preexist in the unactivated gp41 protein, but that its formation is required for fusion activity. Peptides corresponding to regions within each helical segment are relatively potent inhibitors of fusion and entry, with the C peptide significantly more potent (effectively inhibiting HIV-1-mediated cell-cell fusion and viral infection at nanomolar concentrations) [17, 21, 22] . In light of the gp41 core structure and the rearrangements seen in HA 2 , it seems plausible that these peptides work by interfering with the interhelical interactions between the N and C helices within gp41 [17, 22] . Binding of peptides to the complementary helix within gp41 would, therefore, exert a dominant-negative effect on fusion.
These peptide experiments also suggest that blocking fusion protein activation by interfering with the association of N and C helices could be an effective strategy for drugs directed against AIDS. The gp41 structure provides a rational basis for designing small molecule inhibitors of helix association [7, 8] . In particular, a deep, conserved pocket on the surface of the amino-terminal helix bundle that accommodates two tryptophan residues from the C helix is a promising target for the design of small molecules that might block the formation of the antiparallel structure [7] . If, in fact, the folding of buttressing helices to form a six-helix bundle turns out to be a common feature in viral fusion protein activation, the potential for exploiting this feature in developing new drugs against HIV-1 and other viruses will be even greater.
